Biotech | January 04, 2022
USFDA grants ILiAD Biotechnologies Fast Track Designation for pertussis vaccine
BPZE1 is the most advanced next-generation pertussis vaccine currently in clinical development
BPZE1 is the most advanced next-generation pertussis vaccine currently in clinical development
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
The Covid-19 At-Home Test uses a simple nasal swab sample to enable individuals to self-test at home and receive accurate, reliable and quick results in as few as 20 minutes for SARS-CoV-2 and all known variants of concern, including Omicron
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
Trivector Biomed has been promoting its Novaerus air disinfection solution across hospitals and health care facilities across India.
The test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of Covid-19
RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus
Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
Subscribe To Our Newsletter & Stay Updated
